Transaction #30894 · Form 4 · 0001373604-26-000050
Outset Medical, Inc. · Purchase · Common Stock
Outset Medical, Inc. · Transacted October 1, 2026 · Filed October 5, 2026
What does this filing report?
An SEC Form 4 filing for Outset Medical, Inc. records a purchase involving Common Stock on October 1, 2026. The reported quantity was 228,334. The filing date is October 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Outset Medical, Inc.
- Company CIK
- 0001484612
- Security type
- Non-derivative
- Acquisition type
- Purchase · Code P
- Quantity acquired
- 228,334
- Reported price
- 3.53 · See footnotes
- Reference value
- 806,019.02
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 2,748,035
- Ownership description
- Holdings of BML Investment Partners, L.P.
- SEC acceptance time
- Oct 5, 2026, 7:24 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Leonard Braden Michael ↗
10% owner
CIK 0001373603
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
- F2
- The shares were purchased in multiple transactions between $2.90 and $3.85 with an average price of $3.53.
- F3
- The shares were purchased in multiple transactions at an average price of $3.8758 per share.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.